The vascular theory of ED: why blood flow comes before anything else

Most ED is not a testosterone problem. Most ED is not a psychological problem. Most ED is a blood flow problem — and understanding that changes everything about how to approach it.

TL;DR

• Erections depend on blood flow, which depends on healthy blood vessel function.
• Endothelial dysfunction — the same process that precedes heart attacks — is the leading cause of ED in men over 40.
• ED in men under 50 is an independent predictor of future cardiovascular events in the published literature.

What it is

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. About 30 million men in the US are affected by some degree of ED (NIH MedlinePlus, 2024).

The prevailing medical framework in 2026 treats ED primarily as a vascular condition — specifically, as a manifestation of endothelial dysfunction (in plain English: impaired function in the cells that line blood vessels). This is the same underlying process that contributes to cardiovascular disease.

How it works

An erection is a hydraulic event. It requires blood to flow rapidly into the spongy tissue of the penis and stay there long enough to maintain rigidity. Here is the sequence:

1. Sexual stimulation triggers the release of nitric oxide (NO) — a signaling molecule that relaxes the smooth muscle in blood vessel walls.
2. Relaxed blood vessels dilate (widen). Blood flows in.
3. The inflowing blood compresses veins, trapping blood in the erectile tissue.
4. This trapped blood pressure creates and maintains the erection.

When endothelial function is impaired — as it is in cardiovascular disease, diabetes, hypertension (high blood pressure), and metabolic syndrome — nitric oxide production declines. Vessels don’t dilate as effectively. Blood flow is reduced. The hydraulic mechanism fails.

Phosphodiesterase-5 inhibitors (PDE5 inhibitors — the drug class that includes sildenafil and tadalafil, sold as Viagra and Cialis) work by preventing the breakdown of the signals that promote blood vessel dilation. They don’t fix the underlying endothelial problem. They compensate for it temporarily.

Who asks about it

Men who are frustrated that PDE5 inhibitors work sometimes but not reliably, or who want to understand whether the root cause is something that can be addressed rather than just managed, frequently ask about the vascular mechanism. Clinicians working in men’s health often start an ED workup with cardiovascular labs precisely because the underlying mechanism is shared.

What the research says

A landmark study in the Journal of the American College of Cardiology found that men with ED who had no other known cardiovascular risk factors were at significantly elevated risk of major cardiovascular events over the following 7 years compared to age-matched men without ED (Thompson IM et al., 2005). About 1 in 5 men with ED and no known cardiac disease in that study had a cardiovascular event within 7 years.

A 2019 review confirmed that endothelial dysfunction is measurable in the penile vasculature before it becomes apparent in the coronary arteries — meaning ED may appear years before heart disease (PMC, 2019). The penile arteries are smaller, so the same degree of endothelial dysfunction affects them first.

What to know before considering it

The correct starting point for ED evaluation is a medical workup — including cardiovascular markers, metabolic panels, testosterone, and blood pressure — not a prescription. Understanding whether the cause is primarily vascular, hormonal, neurological, or psychological changes the approach entirely.

Lifestyle factors with the strongest evidence for improving vascular-related ED include aerobic exercise, blood pressure normalization, smoking cessation, and metabolic health optimization (including insulin sensitivity).

The Halftime POV

ED is not embarrassing — it is informative. A man who develops ED in his 40s has a years-long window to act on the underlying vascular health signals before those same signals show up as coronary disease. Treating it as a cosmetic problem to be managed with a pill misses the point. The Halftime approach is to find the underlying driver — and fix it.

Related reading:

• Erectile dysfunction as a vascular-health signal
• PT-141 (bremelanotide): how melanocortin signaling affects desire
• Biomarkers commonly tracked during peptide protocols

FAQ

Q: What causes most ED? A: A vascular component — specifically endothelial dysfunction — underlies the majority of cases. Cardiovascular disease, diabetes, metabolic syndrome, and hypertension are the leading risk factors.

Q: Is ED a sign of heart disease? A: It can be an early indicator. Men under 50 with ED have statistically higher cardiovascular risk in subsequent years. A cardiovascular workup is often warranted.

Q: Do PDE5 inhibitors fix the underlying cause? A: No. They compensate for endothelial dysfunction by preserving the vasodilation signal. Addressing the underlying metabolic and vascular health is a separate, parallel effort.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.

Sources

• Thompson IM et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA, 2005
• Shamloul R, Ghanem H. Erectile dysfunction. Lancet, 2013 — summarized in NIH PMC, 2019
• NIH MedlinePlus. Erectile Dysfunction, 2024